News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Daily News INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease Michael O'Riordan July 12, 2022